191 related articles for article (PubMed ID: 19442534)
41. In vitro demonstration of the heavy-atom effect for photodynamic therapy.
Gorman A; Killoran J; O'Shea C; Kenna T; Gallagher WM; O'Shea DF
J Am Chem Soc; 2004 Sep; 126(34):10619-31. PubMed ID: 15327320
[TBL] [Abstract][Full Text] [Related]
42. Characterization and optimization of mTHPP nanoparticles for photodynamic therapy of head and neck cancer.
Ding H; Mora R; Gao J; Sumer BD
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):612-7. PubMed ID: 21727244
[TBL] [Abstract][Full Text] [Related]
43. Investigation of human serum albumin (HSA) binding specificity of certain photosensitizers related to pyropheophorbide-a and bacteriopurpurinimide by circular dichroism spectroscopy and its correlation with in vivo photosensitizing efficacy.
Chen Y; Miclea R; Srikrishnan T; Balasubramanian S; Dougherty TJ; Pandey RK
Bioorg Med Chem Lett; 2005 Jul; 15(13):3189-92. PubMed ID: 15936945
[TBL] [Abstract][Full Text] [Related]
44. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
45. Aptamer-Pyropheophorbide a Conjugates with Tumor Spheroid Targeting and Penetration Abilities for Photodynamic Therapy.
Xiong H; Yan J; Cai S; He Q; Wen N; Wang Y; Hu Y; Peng D; Liu Y; Liu Z
Mol Pharm; 2020 Aug; 17(8):2882-2890. PubMed ID: 32584586
[TBL] [Abstract][Full Text] [Related]
46. Conjugated PDT drug: photosensitizing activity and tissue distribution of PEGylated pheophorbide a.
Rapozzi V; Zacchigna M; Biffi S; Garrovo C; Cateni F; Stebel M; Zorzet S; Bonora GM; Drioli S; Xodo LE
Cancer Biol Ther; 2010 Sep; 10(5):471-82. PubMed ID: 20592494
[TBL] [Abstract][Full Text] [Related]
47. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy.
Bae BC; Na K
Biomaterials; 2010 Aug; 31(24):6325-35. PubMed ID: 20493523
[TBL] [Abstract][Full Text] [Related]
48. The influence of human serum albumin on the photogeneration of singlet oxygen by meso-tetra(4-sulfonatophenyl)porphyrin. An infrared phosphorescence study.
Korínek M; Dedic R; Molnár A; Hála J
J Fluoresc; 2006 May; 16(3):355-9. PubMed ID: 16467969
[TBL] [Abstract][Full Text] [Related]
49. Poly(D, L-lactide-co-glycolide) nanoparticles as delivery agents for photodynamic therapy: enhancing singlet oxygen release and photototoxicity by surface PEG coating.
Boix-Garriga E; Acedo P; Casadó A; Villanueva A; Stockert JC; Cañete M; Mora M; Sagristá ML; Nonell S
Nanotechnology; 2015 Sep; 26(36):365104. PubMed ID: 26293792
[TBL] [Abstract][Full Text] [Related]
50. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.
Gabriel D; Campo MA; Gurny R; Lange N
Bioconjug Chem; 2007; 18(4):1070-7. PubMed ID: 17477499
[TBL] [Abstract][Full Text] [Related]
51. Phototoxic effect of na-pheophorbide a toward osteosarcoma cells in vitro using a laser diode.
Nagai Y; Aizawa S; Iriuchishima T; Goto B; Nagaoka M; Tokuhashi Y; Saito A
Photomed Laser Surg; 2014 Sep; 32(9):481-9. PubMed ID: 25105597
[TBL] [Abstract][Full Text] [Related]
52. Amphiphilic polymers based on polyoxazoline as relevant nanovectors for photodynamic therapy.
Oudin A; Chauvin J; Gibot L; Rols MP; Balor S; Goudounèche D; Payré B; Lonetti B; Vicendo P; Mingotaud AF; Lapinte V
J Mater Chem B; 2019 Aug; 7(32):4973-4982. PubMed ID: 31411611
[TBL] [Abstract][Full Text] [Related]
53. Bioreducible branched polyethyleneimine derivatives physically loaded with hydrophobic pheophorbide A: preparation, characterization, and light-induced cytotoxicity.
Cho H; Li L; Bae YH; Huh KM; Kang HC
Macromol Biosci; 2014 Oct; 14(10):1483-94. PubMed ID: 25130538
[TBL] [Abstract][Full Text] [Related]
54. 131I-Zn-Chlorophyll derivative photosensitizer for tumor imaging and photodynamic therapy.
Ocakoglu K; Er O; Kiyak G; Lambrecht FY; Gunduz C; Kayabasi C
Int J Pharm; 2015 Sep; 493(1-2):96-101. PubMed ID: 26226337
[TBL] [Abstract][Full Text] [Related]
55. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo.
Jang B; Park JY; Tung CH; Kim IH; Choi Y
ACS Nano; 2011 Feb; 5(2):1086-94. PubMed ID: 21244012
[TBL] [Abstract][Full Text] [Related]
56. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms.
Tang W; Xu H; Kopelman R; Philbert MA
Photochem Photobiol; 2005; 81(2):242-9. PubMed ID: 15595888
[TBL] [Abstract][Full Text] [Related]
58. Covalently assembled dopamine nanoparticle as an intrinsic photosensitizer and pH-responsive nanocarrier for potential application in anticancer therapy.
Li H; Zhao Y; Jia Y; Qu C; Li J
Chem Commun (Camb); 2019 Dec; 55(100):15057-15060. PubMed ID: 31777882
[TBL] [Abstract][Full Text] [Related]
59. Photophysical behaviour and photodynamic activity of zinc phthalocyanines associated to liposomes.
Garcia AM; Alarcon E; Muñoz M; Scaiano JC; Edwards AM; Lissi E
Photochem Photobiol Sci; 2011 Apr; 10(4):507-14. PubMed ID: 21152616
[TBL] [Abstract][Full Text] [Related]
60. Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy.
Jiang C; Cheng H; Yuan A; Tang X; Wu J; Hu Y
Acta Biomater; 2015 Mar; 14():61-9. PubMed ID: 25463484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
